Research reveals SLC13A3's role in tumor cell survival and immune therapy resistance, highlighting its potential as a target ...

University of Wisconsin–Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...

Researchers have combined two gene editing methods. This enables them to quickly investigate the significance of many genetic mutations involved in the development and treatment of cancer.